Processing

Please wait...

Settings

Settings

Goto Application

1. MXPA/a/2003/001877 - 2-GUANIDINO-4-ARYL-QUINAZOLINE

Office
Mexico
Application Number PA/a/2003/001877
Application Date 03.03.2003
Publication Number PA/a/2003/001877
Publication Date 17.11.2003
Publication Kind A
IPC
A61K 31/517
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
517ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
A61P 7/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
C07D 239/84
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
70condensed with carbocyclic rings or ring systems
72Quinazolines; Hydrogenated quinazolines
78with hetero atoms directly attached in position 2
84Nitrogen atoms
Applicants MERCK PATENT GESELLSCHAFT HAFTUNG
Inventors WILM, Claudia
GERICKE, Rolf
BEIER, Norbert
Agents JAVIER UHTHOFF ORIVE
Priority Data 10043667 05.09.2000 DE
Title
(EN) 2-GUANIDINO-4-ARYL-QUINAZOLINE
(ES) 2-GUANIDIN-4-ARILQUINAZOLINAS
Abstract
(EN)
The invention relates to compounds of formula (I), wherein Y represents (II) or (III) and Ar, R1, R2, R5, R6, R7 and R8 have the above-mentioned meaning, in addition to the salts and solvates thereof and the use thereof as NHE-3-inhibitors.

(ES)
La presente invención describe compuestos de fórmula I (ver fórmula) donde Y es y Ar R1, R2, R5, R6, R7 y R8 tienen los valores que se definen, y las sales y los solvatos de los mismos, y su uso como inhibidores de NHE-3.

Related patent documents
NO20030999This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
SK200300382This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
IN383/KOLNP/2003This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
ZA200302633This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.